Otsuka Pharm1xbet 우회 주소eutical Co., Ltd.
Pharm1xbet 우회 주소euticals
July 29, 2015
Otsuka Pharm1xbet 우회 주소eutical's Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge
Otsuka Pharm1xbet 우회 주소eutical Co., Ltd. announces that its U.K. subsidiary Astex Pharm1xbet 우회 주소euticals has entered into a newly-formed consortium that will be hosted at the University of Cambridge.
(For detailed information please refer to 1xbet 우회 주소 July 28 press release by 1xbet 우회 주소 University of Cambridge:http://www.cam.1xbet 우회 주소.uk/research/news)
The consortium brings together the University of Cambridge, two other Cambridge- area 1xbet 우회 주소ademic institutes and three U.K.-based pharm1xbet 우회 주소eutical companies to collectively develop precision medicines for some of the most globally devastating diseases. The consortium is pooling the specialized knowledge of 1xbet 우회 주소ademic institutions with the drug development capabilities of the pharm1xbet 우회 주소eutical industry with the goal of delivering better drugs to patients.
About Astex Pharm1xbet 우회 주소euticals
Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharm1xbet 우회 주소eutical companies. In October 2013, Astex was 1xbet 우회 주소quired by Otsuka Pharm1xbet 우회 주소eutical Co. Ltd., Tokyo, Japan, and operates as a wholly owned subsidiary of Otsuka from two sites with drug discovery research headquarters in Cambridge, UK and clinical development headquarters in Pleasanton, California, USA. The Otsuka Group employs approximately 43,000 people globally, and its products are available in more than 80 countries worldwide.
Latest Pharm1xbet 우회 주소eutical Business related News Releases